Business Problem: 

Launching a Novel High-Value Molecular Assay for the Early Identification of Colon Cancer (CRC).

Company Objective: Secure lead customers, reinforce value proposition, demonstrate value of assay to secure partnership deals in international markets.


Build Health Economic Argumentation to support premium pricing, secure first company revenues from KOL, demonstrate value of technology to support international partnerships.

Established first revenue stream for new disruptive technology, supported international deal making.